<DOC>
	<DOCNO>NCT01992328</DOCNO>
	<brief_summary>Immunoglobulin G deficiency subtypes patient asthma six month month intravenous immunoglobulin ( 400mg/kg/4weeks ) infection treatment-related effect reduce frequency asthma exacerbation appreciate .</brief_summary>
	<brief_title>IVIG Treatment Asthmatic Patients With IgG Subclass Deficiency</brief_title>
	<detailed_description>Patients Registration •It require ensure patient meet inclusion criterion clinical trial , free item exclusion criterion , explain participation clinical trial along informed consent form . Procedure •six month month intravenous immunoglobulin ( 400mg/kg/4weeks )</detailed_description>
	<mesh_term>IgG Deficiency</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Immunoglobulin G</mesh_term>
	<criteria>The patient 16 year 75 year Patients diagnose asthma six month ago immunoglobulin G subtypes diagnose immune deficiency 2 year Upper low respiratory tract infection , asthma exacerbation regard . ① calculated creatinine clearance ≧ 50ml/min ALT AST &lt; x 3 time upper limit normal ALP &lt; x 3 time upper limit normal total bilirubin &lt; x 1.5 time upper limit normal within six month onset experiment receive immunoglobulin therapy immune globulin history hypersensitivity reaction six month ago , another clinical trial participant . Systemic steroid immunomodulators , asthma control may affect resource require drug administration . pregnant lactating woman .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Immunoglobulin G Deficiency</keyword>
</DOC>